In silico evidences for the binding of phthalates onto human estrogen receptor α, β subtypes and human estrogen-related receptor γ

REFERENCES

• Hall JM, Couse JF, Korach KS. The multifaceted mechanisms of estradiol and estrogen receptor signaling. J Biol Chem. 2001;276:36869–36872.
   Google Scholar
• HendersonB, RossR, BernsteinL. Estrogens as a cause of human cancer: the Richard and Hinda Rosenthal Foundation award lecture. Cancer Res. 1988;48:246–253.
   PubMed Web of Science ®Google Scholar
• NilssonS, MäkeläS, TreuterE, TujagueM, ThomsenJ, AnderssonG, EnmarkE, PetterssonK, WarnerM, GustafssonJ-Å. Mechanisms of estrogen action. Physiol Rev. 2001;81:1535–1565.
   PubMed Web of Science ®Google Scholar
• ZhaoC, Dahlman-WrightK, GustafssonJ-Å. Estrogen receptor β an overview and update. Nucl Recept Signal. 2008;6. DOI: 10.1621/nrs.06003.
   PubMedGoogle Scholar
• AbadMC, AskariH, O'NeillJ, KlingerAL, MilliganC, LewandowskiF, SpringerB, SpurlinoJ, RentzeperisD. Structural determination of estrogen-related receptor γ in the presence of phenol derivative compounds. J Steroid Biochem Mol Biol. 2008;108:44–54.
   PubMed Web of Science ®Google Scholar
• le MaireA, BourguetW, BalaguerP. A structural view of nuclear hormone receptor: endocrine disruptor interactions. Cell Mol Life Sci. 2010;67:1219–1237.
   PubMed Web of Science ®Google Scholar
• OkuboT, SuzukiT, YokoyamaY, KanoK, KanoI. Estimation of estrogenic and anti-estrogenic activities of some phthalate diesters and monoesters by MCF-7 cell proliferation assay in vitro. Biol Pharm Bull. 2003;26:1219–1224.
   PubMed Web of Science ®Google Scholar
• Sarath JoshMK, PradeepS, BalachandranS, Sudha DeviR, Vijayalakshmi AmmaKS, BenjaminS. Temperature- and solvent-dependent migrations of di(2-ethylhexyl)phthalate, the hazardous plasticizer from commercial PVC blood storage bag. J Polym Res. 2012;19. DOI: 10.1007/s10965-012-9915-4.
   Web of Science ®Google Scholar
• HeudorfU, Mersch-SundermannV, AngererJ. Phthalates: toxicology and exposure. Int J Hyg Environ Health. 2007;210:623–634.
   PubMed Web of Science ®Google Scholar
• PradeepS, FaseelaP, Sarath JoshMK, BalachandranS, Sudha DeviR, BenjaminS. Fungal biodegradation of phthalate plasticizer in situ. Biodegradation. 2012;24:257–267.
   PubMed Web of Science ®Google Scholar
• LatiniG, VerrottiA, De FeliceC. Di-2-ethylhexyl phthalate and endocrine disruption: a review. Curr Drug Targets – Immune Endocr Metabol Disord. 2004;4:37–40.
   PubMedGoogle Scholar
• LiangDW, ZhangT, FangHHP, HeJ. Phthalates biodegradation in the environment. Appl Microbiol Biotechnol. 2008;80:183–198.
   PubMed Web of Science ®Google Scholar
• KochHM, PreussR, AngererJD. Di (2-ethylhexyl) phthalate (DEHP): human metabolism and internal exposure-an update and latest results. Int J Androl. 2006;29:155–165.
   PubMed Web of Science ®Google Scholar
• WittassekM, AngererJ. Phthalates: metabolism and exposure. Int J Androl. 2008;31:131–138.
   PubMed Web of Science ®Google Scholar
• SilvaMJ, BarrDB, ReidyJA, KatoK, MalekNA, HodgeCC, HurtzDIII, CalafatAM, NeedhamLL, BrockJW. Glucuronidation patterns of common urinary and serum monoester phthalate metabolites. Arch Toxicol. 2003;77:561–567.
   PubMed Web of Science ®Google Scholar
• LovekampT, DavisB. Mono-(2-ethylhexyl) phthalate suppresses aromatase transcript levels and estradiol production in cultured rat granulosa cells. Toxicol Appl Pharm. 2001;172:217–224.
   PubMed Web of Science ®Google Scholar
• HabertR, MuczynskiV, LehraikiA, LambrotR, LécureuilC, LevacherC, CoffignyH, PairaultC, MoisonD, FrydmanR. Adverse effects of endocrine disruptors on the foetal testis development: focus on the phthalates. Folia Histochem Cytobiol. 2009;47:67–74.
   PubMed Web of Science ®Google Scholar
• JacobsM. In silico tools to aid risk assessment of endocrine disrupting chemicals. Toxicology. 2004;205:43–53.
   PubMed Web of Science ®Google Scholar
• CozziniP, DellafioraL. In silico approach to evaluate molecular interaction between mycotoxins and the estrogen receptors ligand binding domain: a case study on Zearalenone and its metabolites. Toxicol Lett. 2012;214:81–85.
   PubMed Web of Science ®Google Scholar
• LiF, WuH, LiL, LiX, ZhaoJ, PeijnenburgWJGM. Docking and QSAR study on the binding interactions between polycyclic aromatic hydrocarbons and estrogen receptor. Ecotoxicol Environ Safety. 2012;80:273–279.
   PubMed Web of Science ®Google Scholar
• BabuS, VelloreNA, KasibotlaAV, DwayneHJ, StubblefieldMA, UppuRM. Molecular docking of bisphenol A and its nitrated and chlorinated metabolites onto human estrogen-related receptor-gamma. Biochem Biophys Res Commun. 2012;426:215–220.
   PubMed Web of Science ®Google Scholar
• FriesnerRA, MurphyRB, RepaskyMP, FryeLL, GreenwoodJR, HalgrenTA, SanschagrinPC, MainzDT. Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein–ligand complexes. J Med Chem. 2006;49:6177–6196.
   PubMed Web of Science ®Google Scholar
• ZhuBT, ConneyAH. Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis. 1998;19:1–27.
   PubMed Web of Science ®Google Scholar
• SealA, PassiA, JaleelUCA, WildDJ. In silico predictive mutagenicity model generation using supervised learning approaches. J Cheminform. 2012;4:1–11. DOI: 10.1186/1758-2946-4-10.
   PubMedGoogle Scholar
• CelikL, LundJDD, SchiøttB. Exploring interactions of endocrine-disrupting compounds with different conformations of the human estrogen receptor α ligand binding domain: a molecular docking study. Chem Res Toxicol. 2008;21:2195–2206.
   PubMed Web of Science ®Google Scholar
• SatoM, GlasebrookAL, BryantHU. Raloxifene: a selective estrogen receptor modulator. J Bone Miner Metab. 1994;12:9–20.
   Google Scholar
• MortensenAS, ArukweA. Activation of estrogen receptor signaling by the dioxin-like aryl hydrocarbon receptor agonist, 3,3′,4,4′,5-Pentachlorobiphenyl (PCB126) in salmon in vitro system. Toxicol Appl Pharm. 2008;227:313–324.
   PubMed Web of Science ®Google Scholar
• HarrisCA, HenttuP, ParkerMG, SumpterJP. The estrogenic activity of phthalate esters in vitro. Environ Health Perspect. 1997;105:802–811.
   PubMed Web of Science ®Google Scholar
• ZhangZ, HuY, ZhaoL, LiJ, BaiH, ZhuD, HuJ. Estrogen agonist/antagonist properties of dibenzyl phthalate (DBzP) based on in vitro and in vivo assays. Toxicol Lett. 2011;207:7–11.
   PubMed Web of Science ®Google Scholar
• ZhangZ, SunL, HuY, JiaoJ, HuJ. Inverse antagonist activities of parabens on human oestrogen-related receptor γ (ERRγ): in vitro and in silico studies. Toxicol Appl Pharm. 2013;270:16–22.
   PubMed Web of Science ®Google Scholar
• WallerCL. A comparative QSAR study using CoMFA, HQSAR, and FRED/SKEYS paradigms for estrogen receptor binding affinities of structurally diverse compounds. J Chem Info Comp Sci. 2004;44:758–765.
   PubMedGoogle Scholar
• BlairRM, FangH, BranhamWS, HassBS, DialSL, MolandCL, TongW, ShiL, PerkinsR, SheehanDM. The estrogen receptor relative binding affinities of 188 natural and xenochemicals: structural diversity of ligands. Toxicol Sci. 2000;54:138–153.
   PubMed Web of Science ®Google Scholar
• PradeepS, BenjaminS. Mycelial fungi completely remediate di(2-ethylhexyl)phthalate, the hazardous plasticizer in PVC blood storage bag. J Hazard Mater. 2012;235–236:69–77.
   PubMed Web of Science ®Google Scholar
• PavanB, BiondiC, FerrettiM, LunghiL, PaganettoG. Phthalic acid mimics 17β-estradiol actions in WISH cells. Toxicol Lett. 2001;118:157–164.
   PubMed Web of Science ®Google Scholar
• McLachlanJA, SimpsonE, MartinM. Endocrine disrupters and female reproductive health. Best Pract Res Clin Endocrinol Metab. 2006;20:63–75.
   PubMed Web of Science ®Google Scholar
• CauleyJA, LucasFL, KullerLH, StoneK, BrownerW, CummingsSR. Elevated serum estradiol and testosterone concentrations are associated with a high risk for breast cancer. Ann Intern Med. 1999;130:270–277.
   PubMed Web of Science ®Google Scholar
• MoranFM, VandeVoortCA, OverstreetJW, LasleyBL, ConleyAJ. Molecular target of endocrine disruption in human luteinizing granulosa cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin: inhibition of estradiol secretion due to decreased 17α-hydroxylase/17, 20-lyase cytochrome P450 expression. Endocrinology. 2003;144:467–473.
   PubMed Web of Science ®Google Scholar
• QuesadaI, FuentesE, Viso-LeónMC, SoriaB, RipollC, NadalA. Low doses of the endocrine disruptor bisphenol-A and the native hormone 17β-estradiol rapidly activate transcription factor CREB. FASEB J. 2002;16:1671–1673.
   PubMed Web of Science ®Google Scholar
• MoritoK, HiroseT, KinjoJ, HirakawaT, OkawaM, NoharaT, OgawaS, InoueS, MuramatsuM, MasamuneY. Interaction of phytoestrogens with estrogen receptors alpha and beta. Biol Pharm Bull. 2001;24:351–356.
   PubMed Web of Science ®Google Scholar
• BenjaminS, HanhoffT, BörchersT, SpenerF. An improved molecular test system for the screening of human PPAR transactivation by conjugated linoleic acid isomers and their precursor fatty acids. Eur J Lipid Sci Technol. 2005;107:706–715.
   Web of Science ®Google Scholar
• EscandeA, PillonA, ServantN, CravediJ-P, LarreaF, MuhnP, NicolasJ-C, CavaillèsV, BalaguerP. Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta. Biochem Pharmacol. 2006;71:1459–1469.
   PubMed Web of Science ®Google Scholar
• WeiserMJ, ForadoriCD, HandaRJ. Estrogen receptor beta in the brain: from form to function. Brain Res Rev. 2008;57:309–320.
   PubMed Web of Science ®Google Scholar
• BenjaminS, SpenerF. Conjugated linoleic acids as functional food: an insight into their health benefits. Nutr Metab. 2009;6:1–13. DOI: 10.1186/1743-7075-6-36.
   Google Scholar